KR100496802B1 - 물에 난용성인 활성성분이 캡슐화 되어 있는 동결 건조된 리포솜들을 함유하는 약학적 제제 및 그 제제의 제조공정 - Google Patents

물에 난용성인 활성성분이 캡슐화 되어 있는 동결 건조된 리포솜들을 함유하는 약학적 제제 및 그 제제의 제조공정 Download PDF

Info

Publication number
KR100496802B1
KR100496802B1 KR10-1999-7007538A KR19997007538A KR100496802B1 KR 100496802 B1 KR100496802 B1 KR 100496802B1 KR 19997007538 A KR19997007538 A KR 19997007538A KR 100496802 B1 KR100496802 B1 KR 100496802B1
Authority
KR
South Korea
Prior art keywords
trehalose
liposomes
freeze
temperature
lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR10-1999-7007538A
Other languages
English (en)
Korean (ko)
Other versions
KR20000075479A (ko
Inventor
카발로지오반니
마르치토레오나르도
Original Assignee
아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이 filed Critical 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이
Publication of KR20000075479A publication Critical patent/KR20000075479A/ko
Application granted granted Critical
Publication of KR100496802B1 publication Critical patent/KR100496802B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR10-1999-7007538A 1997-02-20 1998-02-12 물에 난용성인 활성성분이 캡슐화 되어 있는 동결 건조된 리포솜들을 함유하는 약학적 제제 및 그 제제의 제조공정 Expired - Fee Related KR100496802B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI97A000362 1997-02-20
IT97MI000362A IT1289938B1 (it) 1997-02-20 1997-02-20 Preparazione farmaceutica comprendente liposomi liofilizzati in cui e' incapsulato un principio attivo altamente insolubile in acqua e
PCT/EP1998/000817 WO1998036736A1 (en) 1997-02-20 1998-02-12 Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation

Publications (2)

Publication Number Publication Date
KR20000075479A KR20000075479A (ko) 2000-12-15
KR100496802B1 true KR100496802B1 (ko) 2005-06-22

Family

ID=11376097

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-1999-7007538A Expired - Fee Related KR100496802B1 (ko) 1997-02-20 1998-02-12 물에 난용성인 활성성분이 캡슐화 되어 있는 동결 건조된 리포솜들을 함유하는 약학적 제제 및 그 제제의 제조공정

Country Status (25)

Country Link
US (1) US6319517B1 (https=)
EP (1) EP0981332B1 (https=)
JP (1) JP4290767B2 (https=)
KR (1) KR100496802B1 (https=)
CN (1) CN1089581C (https=)
AR (1) AR011681A1 (https=)
AT (1) ATE285754T1 (https=)
AU (1) AU744115B2 (https=)
BG (1) BG64580B1 (https=)
CA (1) CA2288958C (https=)
CZ (1) CZ295998B6 (https=)
DE (1) DE69828394T2 (https=)
EA (1) EA001637B1 (https=)
ES (1) ES2235320T3 (https=)
GE (1) GEP20022734B (https=)
HU (1) HU225593B1 (https=)
IL (1) IL131327A (https=)
IT (1) IT1289938B1 (https=)
PL (1) PL190628B1 (https=)
PT (1) PT981332E (https=)
SK (1) SK282931B6 (https=)
TR (1) TR199902025T2 (https=)
UA (1) UA70296A (https=)
WO (1) WO1998036736A1 (https=)
ZA (1) ZA981352B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014035206A3 (ko) * 2012-08-31 2014-04-24 중앙대학교 산학협력단 색전용 마이크로스피어의 제조방법 및 약물 함유 나노수송체가 결합된 마이크로스피어의 제조방법

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU762944B2 (en) 1999-06-23 2003-07-10 Cornell Research Foundation Inc. Dehydration/rehydration of marked liposomes on a test device
US6576460B1 (en) 1999-10-28 2003-06-10 Cornell Research Foundation, Inc. Filtration-detection device and method of use
EP1592430A4 (en) * 2003-01-17 2006-05-31 Threshold Pharmaceuticals Inc TREATMENT OF GOOD PROSTATE HYPERPLASIA BY MEANS OF ENERGYSTIC ACTIVE SUBSTANCES
US7825087B2 (en) 2005-04-12 2010-11-02 Elan Pharma International Limited Nanoparticulate and controlled release compositions comprising cyclosporine
WO2008036979A2 (en) * 2006-09-22 2008-03-27 Guilford F Timothy Topical application of melatonin directly or in liposomes for the amelioration of itching and histamine and non-histamine related inflammatory skin changes
CN101049504B (zh) * 2007-04-05 2010-05-19 广州立恩生物科技有限公司 一种脂质体药物载体及其制备方法
US9446147B2 (en) 2011-02-24 2016-09-20 The Ohio State University Membrane stabilizing compositions and methods
EP3572071A1 (en) 2011-10-21 2019-11-27 Jazz Pharmaceuticals Research LLC Lyophilized liposomes
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
US11344497B1 (en) 2017-12-08 2022-05-31 Quicksilver Scientific, Inc. Mitochondrial performance enhancement nanoemulsion
US10722465B1 (en) 2017-12-08 2020-07-28 Quicksilber Scientific, Inc. Transparent colloidal vitamin supplement
KR102649069B1 (ko) 2018-05-31 2024-03-19 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 안면 홍조 개선용 조성물
IL279760B2 (en) 2018-06-27 2025-10-01 Breath Therapeutics Gmbh Pharmaceutical preparations in lyophilized form
CA3104443A1 (en) * 2018-06-27 2020-01-02 Breath Therapeutics Gmbh Inhalable compositions comprising macrocyclic immunosuppressants
JP7079984B2 (ja) 2018-07-28 2022-06-03 エクソコバイオ インコーポレイテッド エキソソームの凍結乾燥方法
KR102163806B1 (ko) 2018-07-30 2020-10-07 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 피지분비 감소용 조성물
EA202092892A1 (ru) 2018-12-04 2021-05-27 Брес Терапьютикс Гмбх Ингаляционные композиции, содержащие макроциклические иммуносупрессанты
US11291702B1 (en) 2019-04-15 2022-04-05 Quicksilver Scientific, Inc. Liver activation nanoemulsion, solid binding composition, and toxin excretion enhancement method
EP3990433A4 (en) 2019-06-25 2023-07-26 Translatum Medicus Inc. METHODS FOR THE MANUFACTURE OF 2-((1-BENZYL-1H-INDAZOL-3-YL)METHOXY)-2-METHYLPROPANOIC ACID AND ITS DERIVATIVES
CN111358955B (zh) * 2020-04-01 2023-05-02 重庆理工大学 一种用于治疗脂质代谢疾病的炎症靶向的宾达利纳米粒、制备方法及其应用
JP7508359B2 (ja) * 2020-12-11 2024-07-01 株式会社東芝 脂質粒子の製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1173360A (en) * 1979-06-22 1984-08-28 Jurg Schrank Pharmaceutical preparations
FR2542749B1 (fr) * 1983-03-18 1985-07-12 Beghin Say Sa Copolymere allyloligosaccharide-acrylique salifie, procede de preparation du copolymere et application comme super-absorbant
US4857319A (en) * 1985-01-11 1989-08-15 The Regents Of The University Of California Method for preserving liposomes
US4963362A (en) * 1987-08-07 1990-10-16 Regents Of The University Of Minnesota Freeze-dried liposome mixture containing cyclosporin
US5683714A (en) * 1991-04-19 1997-11-04 Nexstar Pharmaceuticals, Inc. Liposomal cyclosporin pharmaceutical formulation
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
GB9320668D0 (en) * 1993-10-07 1993-11-24 Secr Defence Liposomes containing particulare materials
AU683957B2 (en) * 1993-11-05 1997-11-27 Amgen, Inc. Liposome preparation and material encapsulation method

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014035206A3 (ko) * 2012-08-31 2014-04-24 중앙대학교 산학협력단 색전용 마이크로스피어의 제조방법 및 약물 함유 나노수송체가 결합된 마이크로스피어의 제조방법

Also Published As

Publication number Publication date
HU225593B1 (en) 2007-05-02
DE69828394T2 (de) 2005-12-08
EP0981332B1 (en) 2004-12-29
JP4290767B2 (ja) 2009-07-08
KR20000075479A (ko) 2000-12-15
EP0981332A1 (en) 2000-03-01
WO1998036736A1 (en) 1998-08-27
EA199900751A1 (ru) 2000-10-30
UA70296C2 (uk) 2004-10-15
CZ292599A3 (cs) 2000-01-12
TR199902025T2 (xx) 1999-11-22
IL131327A (en) 2004-07-25
HK1026148A1 (en) 2000-12-08
AU744115B2 (en) 2002-02-14
UA70296A (uk) 2004-10-15
AR011681A1 (es) 2000-08-30
ZA981352B (en) 1998-08-19
JP2001519776A (ja) 2001-10-23
ITMI970362A1 (it) 1998-08-20
AU6496998A (en) 1998-09-09
CA2288958A1 (en) 1998-08-27
ES2235320T3 (es) 2005-07-01
GEP20022734B (en) 2002-07-25
ATE285754T1 (de) 2005-01-15
BG64580B1 (bg) 2005-08-31
CN1089581C (zh) 2002-08-28
CA2288958C (en) 2007-08-21
IL131327A0 (en) 2001-01-28
PT981332E (pt) 2005-05-31
HUP0001464A3 (en) 2001-12-28
PL190628B1 (pl) 2005-12-30
CZ295998B6 (cs) 2005-12-14
CN1248163A (zh) 2000-03-22
DE69828394D1 (de) 2005-02-03
EA001637B1 (ru) 2001-06-25
SK282931B6 (sk) 2003-01-09
SK111099A3 (en) 2000-05-16
US6319517B1 (en) 2001-11-20
HUP0001464A2 (hu) 2000-10-28
PL335207A1 (en) 2000-04-10
BG103738A (en) 2000-05-31
IT1289938B1 (it) 1998-10-19

Similar Documents

Publication Publication Date Title
KR100496802B1 (ko) 물에 난용성인 활성성분이 캡슐화 되어 있는 동결 건조된 리포솜들을 함유하는 약학적 제제 및 그 제제의 제조공정
US4877561A (en) Method of producing liposome
US5262168A (en) Prostaglandin-lipid formulations
US4927571A (en) Preparation of injectable doxorubicin/liposome suspension
US5082664A (en) Prostaglandin-lipid formulations
RU2216315C2 (ru) Способ получения липосом
JPH08505882A (ja) リポソーム調製法及び物質のカプセル化方法
KR100515249B1 (ko) 고 수불용성의 활성 성분을 함유한 수용성 약학적 조성물
CA2279259A1 (en) Pain reducing parenteral liposome formulation
Nounou et al. Influence of different sugar cryoprotectants on the stability and physico-chemical characteristics of freeze-dried 5-fluorouracil plurilamellar vesicles
HK1026148B (en) Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation
EP0496824B1 (en) Reconstitution method
NO890097L (no) Liposom/doksorubicin-sammensetning og fremgangsmaate.
MXPA99007683A (en) Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water
EP1181928A1 (en) Microliposomes and process for producing the same

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

N231 Notification of change of applicant
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

FPAY Annual fee payment

Payment date: 20130422

Year of fee payment: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

FPAY Annual fee payment

Payment date: 20140513

Year of fee payment: 10

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20150615

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20150615

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301